Compare Viatris Inc (VTRS) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Viatris Inc vs Utilities Select Sector SPDR Fund — how do they compare? Viatris Inc trades at $16.45 (market cap $18.95B), while Utilities Select Sector SPDR Fund trades at $43.21. The key difference: Viatris Inc pays a 2.91% dividend while Utilities Select Sector SPDR Fund pays none, and Viatris Inc is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| VTRS | XLU | |
|---|---|---|
Market Cap | $18.95B | — |
Sector | Health | — |
52-Week High | $17.86 | $47.73 |
52-Week Low | $9.49 | $41.86 |
Enterprise Value | $31.07B | — |
Dividend Yield | 2.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Viatris (VTRS) trades at $16.61, down 1.6% on the day, with a bullish technical signal but mixed moving averages. The company reported Q2 2026 EPS of $0.69, beating estimates, and revenue growth of 5% year-over-year. Despite negative net income margins, strong cash flow generation supports dividends and buybacks. Recent news highlights pipeline progress and a higher 2026 outlook.
Outlook: Viatris shows operational strength with consistent earnings beats and cash flow, but high P/E and negative profitability pose risks. Investment opportunity lies in deleveraging and pipeline advancements, while headwinds include generic drug pricing pressure and regulatory uncertainty. Analyst sentiment is mixed with a hold-heavy consensus.
XLU trades at $43.45, up 0.86% with a bullish technical signal despite bearish moving averages. The utilities ETF shows neutral oscillators with RSI at 57.53, trading near key support at $43. Recent news highlights XLU's defensive positioning amid market volatility and AI power demand growth, though some analysts question its AI exposure concentration.
Outlook remains cautiously optimistic as utilities benefit from AI-driven power demand and defensive characteristics during economic uncertainty. Key risks include regulatory changes affecting data-center growth and interest rate sensitivity. The sector's stable dividend profile provides income support while growth potential depends on AI infrastructure expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
